Total Payments
$485,303
2024 Payments
$57,423
Companies
69
Transactions
2,663
Medicare Patients
3,188
Medicare Billing
$765,087
Payment Breakdown by Category
Other$369,614 (76.2%)
Food & Beverage$53,055 (10.9%)
Travel$36,581 (7.5%)
Consulting$25,500 (5.3%)
Education$553.03 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $355,174 | 177 | 73.2% |
| Food and Beverage | $53,055 | 2,322 | 10.9% |
| Travel and Lodging | $36,581 | 132 | 7.5% |
| Consulting Fee | $25,500 | 10 | 5.3% |
| Honoraria | $14,440 | 11 | 3.0% |
| Education | $553.03 | 11 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $268,203 | 497 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $107,580 | 245 | $0 (2024) |
| US WorldMeds, LLC | $19,391 | 70 | $0 (2019) |
| Allergan, Inc. | $12,816 | 114 | $0 (2022) |
| ABBVIE INC. | $12,714 | 257 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $12,690 | 177 | $0 (2024) |
| Medtronic USA, Inc. | $9,304 | 96 | $0 (2020) |
| Amneal Pharmaceuticals LLC | $7,292 | 73 | $0 (2024) |
| Abbott Laboratories | $7,099 | 55 | $0 (2024) |
| Medtronic, Inc. | $5,591 | 53 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,423 | 396 | ACADIA Pharmaceuticals Inc ($20,845) |
| 2023 | $76,689 | 434 | ACADIA Pharmaceuticals Inc ($51,043) |
| 2022 | $34,301 | 376 | ACADIA Pharmaceuticals Inc ($16,424) |
| 2021 | $53,713 | 351 | ACADIA Pharmaceuticals Inc ($29,173) |
| 2020 | $39,627 | 240 | ACADIA Pharmaceuticals Inc ($12,888) |
| 2019 | $78,756 | 299 | ACADIA Pharmaceuticals Inc ($64,600) |
| 2018 | $76,050 | 295 | Teva Pharmaceuticals USA, Inc. ($34,325) |
| 2017 | $68,743 | 272 | ACADIA Pharmaceuticals Inc ($42,233) |
All Payment Transactions
2,663 individual payment records from CMS Open Payments — Page 1 of 107
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $68.66 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Neuropsychiatry | ||||||
| 12/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Neuropsychiatry | ||||||
| 12/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology and Neurology | ||||||
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Neurology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $154.77 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $49.58 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: PAIN | ||||||
| 12/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Rare Disease | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: AMANTADINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 771 | 27,627 | $737,780 | $208,505 |
| 2022 | 15 | 760 | 25,720 | $671,563 | $198,198 |
| 2021 | 19 | 799 | 19,571 | $566,663 | $175,262 |
| 2020 | 18 | 858 | 18,703 | $600,204 | $183,123 |
Total Patients
3,188
Total Services
91,621
Medicare Billing
$765,087
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 31 | 13,700 | $178,100 | $67,805 | 38.1% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 36 | 12,951 | $142,461 | $52,593 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 107 | 107 | $49,220 | $16,626 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 195 | $45,825 | $16,426 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 229 | 284 | $44,588 | $16,358 | 36.7% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 30 | 95 | $109,554 | $13,302 | 12.1% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 18 | 53 | $75,495 | $6,756 | 8.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 30 | 30 | $31,110 | $6,310 | 20.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 44 | 71 | $19,880 | $4,849 | 24.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 22 | $10,670 | $2,626 | 24.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 19 | 19 | $9,101 | $1,710 | 18.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 20 | 37 | $5,291 | $1,677 | 31.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 18 | 33 | $10,725 | $1,139 | 10.6% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 22 | 30 | $5,760 | $326.23 | 5.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 34 | 21,080 | $274,040 | $99,578 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 244 | 305 | $46,733 | $18,102 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 198 | $45,314 | $16,986 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 111 | 111 | $50,072 | $16,851 | 33.7% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 11 | 3,700 | $40,700 | $14,661 | 36.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 28 | 80 | $87,839 | $11,930 | 13.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 16 | 44 | $60,238 | $5,341 | 8.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 21 | 21 | $21,777 | $4,651 | 21.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 25 | 38 | $10,159 | $2,854 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 18 | $5,953 | $2,350 | 39.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 18 | 18 | $8,413 | $1,730 | 20.6% |
About Dr. Gerald Calegan, MD
Dr. Gerald Calegan, MD is a Internal Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902873516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Calegan, MD has received a total of $485,303 in payments from pharmaceutical and medical device companies, with $57,423 received in 2024. These payments were reported across 2,663 transactions from 69 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($355,174).
As a Medicare-enrolled provider, Calegan has provided services to 3,188 Medicare beneficiaries, totaling 91,621 services with total Medicare billing of $765,087. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Neurology
- Location Baton Rouge, LA
- Active Since 03/02/2006
- Last Updated 05/31/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902873516
Products in Payments
- NUPLAZID (Drug) $268,203
- AUSTEDO (Drug) $70,774
- Austedo XR (Drug) $31,537
- UBRELVY (Drug) $20,149
- Xadago (Drug) $19,278
- INGREZZA (Drug) $12,040
- ACTIVA (Device) $11,280
- RYTARY (Drug) $7,314
- INFINITY (Device) $6,964
- Xeomin (Biological) $3,961
- SD809-HD (Drug) $3,762
- QULIPTA (Drug) $2,925
- BOTOX (Biological) $1,283
- SENSIGHT (Device) $1,108
- GOCOVRI (Drug) $1,063
- NURTEC ODT (Drug) $983.79
- INBRIJA (Drug) $870.94
- MazorX Renaissance (Device) $816.51
- PERCEPT PC BRAINSENSE (Device) $771.38
- Percept (Device) $710.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baton Rouge
Dr. Jonathon Chapman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Donna Ryan, M.d, M.D
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Abdulla Majid-Moosa, D.o, D.O
Internal Medicine — Payments: $133,349
Internal Medicine $133,349
Dr. Sean Shannon, M.d, M.D
Internal Medicine — Payments: $132,839
Internal Medicine $132,839
Dr. Randall Beyl, Md, MD
Internal Medicine — Payments: $120,599
Internal Medicine $120,599
Andrew Dalovisio, M.d, M.D
Internal Medicine — Payments: $105,923
Internal Medicine $105,923